A detailed history of Bay Bridge Capital Group, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Bay Bridge Capital Group, LLC holds 2,107 shares of JNJ stock, worth $328,228. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,107
Previous 7,443 71.69%
Holding current value
$328,228
Previous $1.09 Billion 68.62%
% of portfolio
0.25%
Previous 0.85%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$145.48 - $167.38 $776,281 - $893,139
-5,336 Reduced 71.69%
2,107 $341 Million
Q2 2024

Aug 01, 2024

BUY
$144.38 - $157.78 $35,661 - $38,971
247 Added 3.43%
7,443 $1.09 Billion
Q1 2024

Apr 26, 2024

BUY
$155.22 - $162.74 $1.12 Million - $1.17 Million
7,196 New
7,196 $1.07 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bay Bridge Capital Group, LLC Portfolio

Follow Bay Bridge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Bridge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Bridge Capital Group, LLC with notifications on news.